| Phase 2 |
| NCT07221942 |
Pembrolizumab Maintenance After Enfortumab Vedotin (EV)/Pembro Induction in Front-Line… |
Metastatic Urothelial Carcinoma |
Recruiting |
| NCT05263050 |
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma… |
Metastatic Renal Cell Carcinoma |
Recruiting |
| NCT05800574 |
Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx… |
Oropharynx Cancer |
Recruiting |
| NCT05800587 |
Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer |
Lung Cancer |
Recruiting |
| NCT05800600 |
Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy |
Anemia |
Recruiting |
| NCT05923190 |
Enfortumab Vedotin Schedule De-escalation in Metastatic Urothelial Carcinoma |
Urothelial Carcinoma |
Active, Not Recruiting |
| NCT03114527 |
Phase II Trial of Ribociclib and Everolimus in Advanced Dedifferentiated Liposarcoma… |
Soft Tissue Sarcoma |
Active, Not Recruiting |
| NCT03125928 |
Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients… |
HER2-positive Breast Cancer |
Active, Not Recruiting |
| NCT03527108 |
Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLC |
Non Small Cell Lung Cancer |
Active, Not Recruiting |
| NCT03548961 |
Organ Preservation in Early Rectal Cancer Patients |
Rectal Cancer |
Active, Not Recruiting |
| NCT03786692 |
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage… |
Non-Small Cell Carcinoma of Lung, TNM Stage 4 |
Active, Not Recruiting |
| Phase 1/2 |
| NCT03172754 |
Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma |
Renal Cell Carcinoma |
Active, Not Recruiting |
| Phase 1 |
| NCT07455032 |
Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally… |
Squamous Cell Carcinoma of Head and Neck |
Recruiting |
| Early Phase 1 |
| NCT05498792 |
Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma |
Locally Advanced or Metastatic Melanoma |
Recruiting |
| NCT05365893 |
PHL Treatment in Pancreatic Cancer |
Pancreatic Ductal Adenocarcinoma |
Active, Not Recruiting |
| Not specified |
| NCT06782581 |
CARE Study: Cancer, Asian Americans, and Relationship Enrichment |
Neoplasm |
Recruiting |
| NCT06904339 |
Communication About Sexual Health in Gynecologic Cancer |
Gynecologic Cancers |
Recruiting |
| NCT03291028 |
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and… |
Renal Cell Carcinoma |
Active, Not Recruiting |
| NCT04055753 |
Study to Assess TOPO2A as a Biomarker for Sensitivity to Doxorubicin/Doxil in Soft Tissue… |
Soft Tissue Sarcoma |
Active, Not Recruiting |
| NCT04452357 |
Pulse-low-dose Rate (PLDR) Radiation in Pancreatic Cancer |
Pancreatic Cancer |
Active, Not Recruiting |
| NCT07638410 |
Prehabilitation in High-risk Oncologic Surgery |
Pancreatic Cancer |
Not Yet Recruiting |